Solventum Corporation (SOLV) Current Ratio: 1.23
Is Solventum Corporation’s current ratio high or low?
Solventum Corporation's current ratio of 1.23 is 14% below its 4-year average of 1.43, near the low end of its 4-year range (1.20–1.70).
As of Friday, June 12, 2026. 1.23% above its 12-month average of 1.21.
SOLV Current Ratio Chart
SOLV Average Current Ratio Chart
SOLV Current vs Average Current Ratio Chart
SOLV Current Ratio Metrics
CURRENT RATIO
1.23
CURRENT RATIO AVG TTM
1.21
CURRENT RATIO AVG 3Y
1.40
CURRENT RATIO AVG 5Y
1.43
CURRENT RATIO AVG 10Y
1.43
CURRENT RATIO AVG 15Y
1.43
CURRENT RATIO AVG 20Y
1.43
CURRENT VS TTM AVG
+1.23%
CURRENT VS 3Y AVG
-11.99%
CURRENT VS 5Y AVG
-13.99%
CURRENT VS 10Y AVG
-13.99%
CURRENT VS 15Y AVG
-13.99%
CURRENT VS 20Y AVG
-13.99%
SOLV Competitors' Current Ratio
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $13.72B | 1.23 | 1.21 | 1.40 | 1.43 |
| Align Technology, Inc. (ALGN) | $12.64B | 1.36 | 1.29 | 1.26 | 1.29 |
| Baxter International Inc. (BAX) | $10.58B | 2.31 | 1.83 | 1.71 | 1.91 |
| Hologic, Inc. (HOLX) | $16.97B | 3.75 | 3.72 | 3.76 | 3.20 |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | 1.29 | 1.35 | 1.39 | 1.37 |
| Tempus AI, Inc. (TEM) | $8.65B | 3.13 | 2.71 | 2.36 | 3.23 |
| Bio-Rad Laboratories, Inc. (BIO) | $7.91B | 5.62 | 6.05 | 5.87 | 4.96 |
| Moderna, Inc. (MRNA) | $19.70B | 3.29 | 3.48 | 3.28 | 2.72 |
| Hims & Hers Health, Inc. (HIMS) | $6.44B | 1.90 | 1.84 | 2.80 | 3.67 |
| BioNTech SE (BNTX) | $22.39B | 7.54 | 7.50 | 7.96 | 6.49 |
Liquidity Analysis
Current Ratio
1.23
Quick Ratio
0.89
Solventum Corporation Current Ratio Formula & Definition
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Solventum Corporation Current Ratio FAQ
- What is the current ratio for Solventum Corporation (SOLV)?
- The current ratio for SOLV stock is 1.23.
- Is Solventum Corporation's current ratio high or low?
- Solventum Corporation's current ratio of 1.23 is 14% below its 4-year average of 1.43, near the low end of its 4-year range (1.20–1.70).
- What is the TTM average current ratio for Solventum Corporation (SOLV)?
- The TTM average current ratio for SOLV stock is 1.21.
- What is the 3Y average current ratio for Solventum Corporation (SOLV)?
- The 3Y average current ratio for SOLV stock is 1.40.
- What is the 5Y average current ratio for Solventum Corporation (SOLV)?
- The 5Y average current ratio for SOLV stock is 1.43.
- What is the 10Y average current ratio for Solventum Corporation (SOLV)?
- The 10Y average current ratio for SOLV stock is 1.43.
- What is the 15Y average current ratio for Solventum Corporation (SOLV)?
- The 15Y average current ratio for SOLV stock is 1.43.
- What is the 20Y average current ratio for Solventum Corporation (SOLV)?
- The 20Y average current ratio for SOLV stock is 1.43.
Solventum Corporation Current Ratio History
| DATE | CURRENT RATIO |
|---|---|
| 2025-12-31 | 1.23 |
| 2024-12-31 | 1.20 |
| 2023-12-31 | 1.46 |
| 2022-12-31 | 1.70 |
| 2021-12-31 | 1.56 |
Related Metrics
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson